A recently approved brand drug for bipolar disorder will have little impact on how health plans cover these medications, experts say. Health plans will continue to encourage the use of less expensive generic bipolar drugs.
- Datapoint, Drug Benefits
- Abstract, Health Plans
- People on the Move
- Health Plans
- Datapoint, Medicare and Medicaid